<DOC>
	<DOCNO>NCT02672878</DOCNO>
	<brief_summary>Treatment patient in-stent restenosis ( ISR ) remain challenge . This study ass efficacy Bioresorbable Vascular Scaffolds ( BVS ) ( Abbott Vascular ) treatment patient suffer ISR .</brief_summary>
	<brief_title>Restenosis Intrastent : Bioresorbable Vascular Scaffolds Treatment ( RIBS VI )</brief_title>
	<detailed_description>Treatment patient ISR remain challenge . Currently drug-eluting stent ( DES ) drug-coated balloon ( DCB ) consider strategy choice set . However , data value BVS patient ISR scarce . BVS effective inhibit neointimal proliferation avoid need implant new permanent metal layer . Accordingly , currently , major interest elucidate potential value BVS patient ISR . This prospective Spanish multicenter study assess clinical angiographic outcome patient ISR treat BVS . BVS implant select patient ( fulfil inclusion exclusion criterion ) present either BMS-ISR DES-ISR . Care pay ensure device optimization . Angiographic follow-up obtain 6-9 month . A centralized angiographic corelab use provide QCA measurement . Clinical follow-up also obtain 1 year yearly . Clinical event adjudicate independent Clinical Event Committee .</detailed_description>
	<criteria>Instent restenosis ischemia . Signed Informed Consent IRB approval INCLUSION CRITERIA : PATIENT Age &gt; 20 &lt; 85 year age Acceptance late angiographic evaluation Angina objective evidence ischemia LESION ISR ( &gt; 50 % diameter stenosis visual assessment ) Previous stent location know EXCLUSION CRITERIA : PATIENT Inclusion clinical research protocol Allergy antiplatelet agent Women childbearing age Severe associate systemic disease ( include renal liver failure ) diseases affect life expectancy Recent myocardial infarction Time index stent implantation &lt; 1 month Anticipated difficulty late angiographic evaluation LESION Stent thrombosis large thrombus within stent Angiographic failure initial stent implantation persistence large dissection . Severe tortuosity calcification major difficulty previous stent implantation Vessel diameter &lt; 2.25 mm ( visual assessment ) Stenosis outside stent stent edge ( edge ISR eligible ) Very diffuse ISR ( &gt; 30 mm length )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>In-stent restenosis</keyword>
	<keyword>Bioresorbable vascular scaffold</keyword>
	<keyword>Stent</keyword>
	<keyword>Drug-eluting stent</keyword>
	<keyword>Coronary angiography</keyword>
</DOC>